Gov. Asa Hutchinson, along with FDA leadership and other elected officials, cut the ribbon this week on the renovated Building 14 at the FDA’s National Center for Toxicological Research in Jefferson County.
“With over 650 employees, this facility is a significant economic engine for our state and provides critical research for the FDA,” the governor wrote on Twitter.
The $26.8 million project updated more than 16,000 SF of laboratory space and added 10,000 SF of new offices.
The investment was the first U.S. Department of Health & Human Services Non-Recurring Expense Fund project awarded to the FDA, according to Commissioner Neal Sharpless, who shared that figure on Twitter.
“The NCTR is critical to the FDA’s mission by conducting scientific research which generates data for FDA decision-making, and develops and supports innovative tools and approaches that FDA uses to protect and promote individual and public health,” he wrote. “We are committed to strengthening the infrastructure, innovativeness and capacity of the FDA to fulfill its mission. I am very excited about the cutting-edge science that is now possible through these improvements at the NCTR.”
Sen. John Boozman, R-Arkansas, said growth at FDA’s only center outside Washington, D.C., “allows for expanded research opportunities/functions.”
Sign up for Daily E-news
